Salcy & Ceftrawin-T

Win the Fight against Tough Resistant Infections with the Broad Spectrum

Salcy Ceftriaxone 1000 mg + Sulbactam 500 mg Injection

Ceftawin-T Ceftazidime 1000 mg + Tazobactam 125 mg Injection

Powerful Combination to conquer Bacterial Resistance

  • Ceftriaxone and Ceftazidime are bactericidal antibiotics, inhibit bacterial cell wall synthesis by binding to one or more penicillin binding proteins (PBPs)
  • Sulbactam and Tazobactam are β-lactamase inhibitors act primarily by irreversible inactivation of β-lactamases

Indications:

  • Respiratory Tract Infections
  • Acute Bacterial Otitis Media
  • Sepsis
  • Meningitis
  • Nosocomial Infections
  • Pre & Post operative Surgical Prophylaxis
  • Intra-abdominal Infections
  • Pelvic Inflammatory Disease
  • Infections of Bones, Joint, Skin & Soft Tissue and Wounds
  • Renal & Urniary Tract Infections
  • Sexually Transmitted Diseases

Benefits:

  • Combination of Coverage, Efficacy & Safety offer Increased Success Rate
  • Broad Spectrum Antibacterial activity
  • Least chances of Resistance
  • Superior efficacy than Ceftriaxone alone
  • Readily diffuses to most body fluids without harmful effects on brain and spinal fluid.
  • Enhanced bioavailability with proven safety even in children and elderly

Dose:

  • Adults: Salcy 1 to 2g OD or BID given 12 hourly. Max 4g/day Ceftawin-T 1000/125 mg OD or BID given 12 hourly. Max 4g/day
  • Paediatric Patients: Salcy 1 or Ceftawin-T For skin & soft tissue infections: 50 to 75 mg/kg OD or BID given 12 hourly. Max 1g/day For acute bacterial otitis media: 50 mg/kg iv/im. Max 1g/day
  • Salcy 1 or Ceftawin-T Meningitis: 100 mg/kg iv/im. Max 4g/day